The latest patent addresses reagent formulations for Orthopeutics’ injectable tissue-repair products. Orthopeutics has commenced the human clinical trials phase of NEXT for degenerative disc disease, engaging multiple clinical specialties to validate their custom injection-delivery protocol, with overseas first-in-man trials beginning soon.
More Articles on Orthopedic Devices:
Smith & Nephew Launches TRIGEN Low-Profile Screw
Mazor Robotics Finalizes $15M in Financing
Implantate Extends Contracts of All Board Members
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 18–20 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
